A1) Once you submit your idea/projects to our Website Suggestion, Daewoong Pharma will reach you within 7 days with initial feedback.
2) please contact us by email (opencollaboration@daewoong.co.kr) or phone (+82- 2-2190-6923)

AAn in-depth review will be conducted after the CDA contract has been signed and the data has been provided at the additional process step. After passing the 2nd review, the contract will be concluded after negotiating the terms of the contract, and then the collaboration will proceed.

AAccording to the contract concluded for O/C, we plan to set the collaboration phase/section gate in advance, make it possible to decide whether to maintain/stop collaborating at the gate point, and even if it is the gate position, you may terminate it if there are reasonable grounds for termination.

AOnce the collaboration program with Daewoong Pharma is established, contracts are concluded according to the project/technology development stage, and Daewoong Pharma's core competencies listed on the website can be provided according to each cooperation model. At this time, what is provided by Daewoong Pharma is available under certain conditions. Daewoong Pharma will have the right to negotiate for the results of joint research and individual research, the terms of the contract will be negotiated according to factors such as contributions, development stages, and so on.

AYou should first consider whether the proposed project is novel and the scientific basis is valid through research materials such as papers and posters published previously. In particular, if the proposed ideas and research results are likely to find new therapeutic areas, it would be advantageous for selecting open collaboration project.

AAfter submitting the research plan, Daewoong Pharma will proceed as follows. Daewoong Pharma review → delivery of review comments to researchers (approved, supplemented, returned according to review comments) → completion of final examination → contract progress between Daewoong Pharma and researcher → start of research

AAcademic presentation on the results obtained through the collaboration with Daewoong Pharma can be published in negotiation with each other.

AParticipation in government tasks is also determined by the official proposal and review process. Daewoong Pharma's R&D future direction and the current state of project resources will be considered and decision will be made according to the internal procedures. The proponent will be notified with the results.

AWhen you become Daewoong Pharma’s partner, you can utilize the diverse core competencies of Daewoong Pharma. In addition, it’s possible to make various collaboration models such as joint research, technology introduction, research cost investment, JV establishment, etc. depending on the stage and level of technology, and the researcher’s compensation will be made accordingly.

AOf course. In addition to Daewoong Pharma's areas of interest, we also accept suggestions from various fields (pharmaceuticals, cosmetics, medical devices, etc.).